Related Experiment Video
Updated: Jun 13, 2025

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
Exploring the Association Between Atopic Dermatitis and Malignancy: A Comprehensive Review with Therapeutic
David L Drum1, Leo S Wan2, Anika G Jallorina1
1California University of Science and Medicine, Colton, CA 92324, USA.
Atopic dermatitis (AD) may influence cancer risk, acting as either a protective or risk factor. This review examines AD
Area of Science:
- Dermatology and Oncology
- Immunology
Background:
- Atopic dermatitis (AD) is a common inflammatory skin condition.
- The link between AD and malignancy risk is debated.
- Proposed mechanisms involve immune activation or chronic inflammation.
Purpose of the Study:
- To review the association between atopic dermatitis and various cancers.
- To explore the impact of AD treatments on malignancy risk.
Main Methods:
- Literature review of studies on atopic dermatitis and cancer.
- Analysis of proposed pathomechanisms.
- Examination of data on biologic therapies for AD.
Main Results:
- AD's role in cancer risk is complex and multifactorial.
- Certain AD treatments, including biologics, may alter malignancy risk.
- Further research is needed to clarify these associations.
Conclusions:
- The relationship between atopic dermatitis and cancer requires further investigation.
- Understanding treatment impacts is crucial for patient management.
More Related Videos
04:12Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA
Published on: December 19, 2019
09:32Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
Published on: September 26, 2019
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against...
The Tumor Microenvironment
Mitogens and the Cell Cycle
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...